These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15307856)

  • 1. Symptom response and healing of erosive esophagitis with proton-pump inhibitors in patients with Helicobacter pylori infection.
    Vakil NB; Traxler BM; Levine D
    Am J Gastroenterol; 2004 Aug; 99(8):1437-41. PubMed ID: 15307856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors.
    Sharma P; Johnson DA; Monyak JT; Illueca M
    Aliment Pharmacol Ther; 2011 Aug; 34(4):487-93. PubMed ID: 21682754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.
    Castell DO; Kahrilas PJ; Richter JE; Vakil NB; Johnson DA; Zuckerman S; Skammer W; Levine JG
    Am J Gastroenterol; 2002 Mar; 97(3):575-83. PubMed ID: 11922549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.
    Devault KR; Johanson JF; Johnson DA; Liu S; Sostek MB
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):852-9. PubMed ID: 16682260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials.
    Gralnek IM; Dulai GS; Fennerty MB; Spiegel BM
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1452-8. PubMed ID: 17162239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
    Johnson DA; Benjamin SB; Vakil NB; Goldstein JL; Lamet M; Whipple J; Damico D; Hamelin B
    Am J Gastroenterol; 2001 Jan; 96(1):27-34. PubMed ID: 11197282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
    Richter JE; Kahrilas PJ; Johanson J; Maton P; Breiter JR; Hwang C; Marino V; Hamelin B; Levine JG;
    Am J Gastroenterol; 2001 Mar; 96(3):656-65. PubMed ID: 11280530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heartburn severity does not predict disease severity in patients with erosive esophagitis.
    Fennerty MB; Johnson DA
    MedGenMed; 2006 Apr; 8(2):6. PubMed ID: 16926745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis.
    Yaghoobi M; Padol S; Yuan Y; Hunt RH
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):583-90. PubMed ID: 20061959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis.
    Fennerty MB; Johanson JF; Hwang C; Sostek M
    Aliment Pharmacol Ther; 2005 Feb; 21(4):455-63. PubMed ID: 15709997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis--results from the EXPO study.
    Labenz J; Armstrong D; Zetterstrand S; Eklund S; Leodolter A
    Aliment Pharmacol Ther; 2009 May; 29(9):959-66. PubMed ID: 19222417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE study.
    Goh KL; Benamouzig R; Sander P; Schwan T;
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):205-11. PubMed ID: 17301646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials.
    Laine L; Fennerty MB; Osato M; Sugg J; Suchower L; Probst P; Levine JG
    Am J Gastroenterol; 2000 Dec; 95(12):3393-8. PubMed ID: 11151867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity does not affect treatment outcomes with proton pump inhibitors.
    Sharma P; Vakil N; Monyak JT; Silberg DG
    J Clin Gastroenterol; 2013 Sep; 47(8):672-7. PubMed ID: 23442835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised clinical trial: a novel rabeprazole extended release 50 mg formulation vs. esomeprazole 40 mg in healing of moderate-to-severe erosive oesophagitis - the results of two double-blind studies.
    Laine L; Katz PO; Johnson DA; Ibegbu I; Goldstein MJ; Chou C; Rossiter G; Lu Y
    Aliment Pharmacol Ther; 2011 Jan; 33(2):203-12. PubMed ID: 21114792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 6-12 months of esomeprazole treatment on the gastric mucosa.
    Genta RM; Rindi G; Fiocca R; Magner DJ; D'Amico D; Levine DS
    Am J Gastroenterol; 2003 Jun; 98(6):1257-65. PubMed ID: 12818266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):593-8. PubMed ID: 20706150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection.
    Gatta L; Vakil N; Ricci C; Osborn JF; Tampieri A; Perna F; Miglioli M; Vaira D
    Am J Gastroenterol; 2004 May; 99(5):823-9. PubMed ID: 15128344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients.
    Peura DA; Haber MM; Hunt B; Atkinson S
    J Clin Gastroenterol; 2010 Mar; 44(3):180-5. PubMed ID: 19687753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole.
    Holtmann G; Cain C; Malfertheiner P
    Gastroenterology; 1999 Jul; 117(1):11-6. PubMed ID: 10381904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.